|
HLA-DQ6
|
Haplotypes
| DQA1*0103:DQB1*0601 DQA1*0102:DQB1*0602 DQA1*0103:DQB1*0603 DQA1*0102:DQB1*0605 DQA1*0102:DQB1*0605 DQA1*0102:DQB1*0609
|
Structure | |
Identifiers | alpha 1 *0102 or *0103
|
EBI-HLA
| DQA1*0102
|
EBI-HLA
| DQA1*0103
|
Identifiers | beta 1 *0601 to *0611
|
EBI-HLA
| DQB1*0601
|
EBI-HLA
| DQB1*0602
|
EBI-HLA
| DQB1*0603
|
EBI-HLA
| DQB1*0604
|
EBI-HLA
| DQB1*0605
|
EBI-HLA
| DQB1*0609
|
Shared data
|
Locus
| chr.6 6p21.31
|
HLA-DQ6 is an HLA-DQ serotype grouping based on antibody recognition of the HLA DQ beta chain. It is synonymous with the HLA-DQB1*06 allelegroup. This group is composed of many similar beta chains. HLA DQB1*0601 to *0605, and *0609 are the most common. These beta chains are linked to certain alpha chain genes DQA1*01 as a result DQ6 serotyped cells were originally recognized as DQ1 since DQ1 recognizes the DQA1*01 allele group gene products. These gene products are DQA1*0101 to *0106. DQ1 also recognizes cells recognized by DQ5.
Additional recommended knowledge
Serology
DQ6, DQ1, and DQ5 recognition of some Some DQB1* alleles
| DQ6
| DQ1 | DQ5 | N
|
allele | % | % | % | size (N)
|
0601 | 64 | 23 | | 675
|
0602 | 67 | 30 | 1 | 5151
|
0603 | 62 | 23 | 2 | 2807
|
0604 | 59 | 27 | 2 | 1592
|
0605 | 76 | 13 | | 358
|
0609 | 48 | 32 | 3 | 149
|
Alleles
DQB1*0601, *0602, *0603, *0604, *0605 and DQB1*0609 are the most common.
DQB1*0601 is generally linked to DQA1*0103 as DQ6.1 and is more common in eastern Asia. DQB1*0602 is commonly lined to DQA1*0102 as DQ6.2 and is common from central Asia into Western Europe, *0602 is also linked to DQA1*0103 in parts of Asia. DQB1*0603 is commonly lined to DQA1*0103 as DQ6.3 and is common from Central Asia into Western Europe, *0603 is also linked to DQA1*0102 in parts of Asia. DQB1*0604 is found at higher frequencies in parts of Asia and is linked almost exclusively to DQA1*0102 as DQ6.4. DQB1*0605 and *0609 are elevated in SW Europe and Africa and are linked to DQA1*0102 as DQ6.5 and DQ6.9, respectively.
Haplotypes
DQ6.1
DQA1*0103:DQB1*0601 (DQ6.1) is found at increased freqeuncies in Asia and is almost
absent in Western Europe. It confers protection from Narcolepsy[1], Type 1 diabetes[2][3], Vogt-Koyanagi-Harada (VKH) syndrome[4], pemphigus vulgaris[5], Multiple sclerosis[6], myasthenia gravis.
DQ6.2
DQA1*0102:DQB1*0602 (DQ6.2) is very common in Eurasia, particularly central Asia and eastern Europe.
hypocretin deficiency associated narcolepsy - with DR15 [1][7]
Myasthenia gravis - α34-49 of AChR recognition[8]
Cervical neoplasia - DQA1*0102 - increased risk - [9]
Primary biliary cirrhosis - Protective. [10]
Multiple sclerosis - DQA1*0102 was the most frequent allele in the MS patients and DQB1*0602 increased significantly in the MS patients.[11][12]
DQ6.3
A1*0103:B1*0603 (DQ6.3) is found in northcentral Europe at moderate frequencies, it is a protective against many autoimmune diseases.
DQ6.4
A1*0102:B1*0604 (DQ6.4) is associated with thymoma induced myastenia gravis[13].
References
- ^ a b Hong SC, Lin L, Lo B, et al (2007). "DQB1*0301 and DQB1*0601 modulate narcolepsy susceptibility in Koreans". Hum. Immunol. 68 (1): 59-68. doi:10.1016/j.humimm.2006.10.006. PMID 17207713.
- ^ Sang Y, Yan C, Zhu C, Ni G (2001). "Relationship between HLA-DRB1 and DQ alleles and the genetic susceptibility to type 1 diabetes". Chin. Med. J. 114 (4): 407-9. PMID 11780465.
- ^ Saruhan-Direskeneli G, Uyar FA, Bas F, et al (2000). "HLA-DR and -DQ associations with insulin-dependent diabetes mellitus in a population of Turkey". Hum. Immunol. 61 (3): 296-302. PMID 10689119.
- ^ Kim MH, Seong MC, Kwak NH, et al (2000). "Association of HLA with Vogt-Koyanagi-Harada syndrome in Koreans". Am. J. Ophthalmol. 129 (2): 173-7. PMID 10682969.
- ^ Niizeki H, Inoko H, Mizuki N, et al (1994). "HLA-DQA1, -DQB1 and -DRB1 genotyping in Japanese pemphigus vulgaris patients by the PCR-RFLP method". Tissue Antigens 44 (4): 248-51. PMID 7871526.
- ^ Amirzargar A, Mytilineos J, Yousefipour A, et al (1998). "HLA class II (DRB1, DQA1 and DQB1) associated genetic susceptibility in Iranian multiple sclerosis (MS) patients". Eur. J. Immunogenet. 25 (4): 297-301. PMID 9777330.
- ^ Peled N, Amar A, Peled E, Brautbar C, Pillar G (2002). "DRB1*1502-DQB1*0601-DQA1*0103 and DRB1*04-DQB1*0302 in Jewish hypersomnolent patients". Sleep Med. 3 (3): 267-70. PMID 14592217.
- ^ Deitiker PR, Oshima M, Smith RG, Mosier DR, Atassi MZ (2006). "Subtle differences in HLA DQ haplotype-associated presentation of AChR alpha-chain peptides may suffice to mediate myasthenia gravis". Autoimmunity 39 (4): 277-88. doi:10.1080/08916930600738581. PMID 16891216.
- ^ Schiff MA, Apple RJ, Lin P, Nelson JL, Wheeler CM, Becker TM (2005). "HLA alleles and risk of cervical intraepithelial neoplasia among southwestern American Indian women". Hum. Immunol. 66 (10): 1050-6. doi:10.1016/j.humimm.2005.09.002. PMID 16386646.
- ^ Mullarkey ME, Stevens AM, McDonnell WM, et al (2005). "Human leukocyte antigen class II alleles in Caucasian women with primary biliary cirrhosis". Tissue Antigens 65 (2): 199-205. doi:10.1111/j.1399-0039.2005.00351.x. PMID 15713222.
- ^ Amirzargar AA, Tabasi A, Khosravi F, et al (2005). "Optic neuritis, multiple sclerosis and human leukocyte antigen: results of a 4-year follow-up study". Eur. J. Neurol. 12 (1): 25-30. doi:10.1111/j.1468-1331.2004.00901.x. PMID 15613143.
- ^ Fernández O, Fernández V, Alonso A, et al (2004). "DQB1*0602 allele shows a strong association with multiple sclerosis in patients in Malaga, Spain". J. Neurol. 251 (4): 440-4. doi:10.1007/s00415-004-0350-2. PMID 15083289.
- ^ Vieira M, Caillat-Zucman S, Gajdos P, Cohen-Kaminsky S, Casteur A, Bach J (1993). "Identification by genomic typing of non-DR3 HLA class II genes associated with myasthenia gravis.". J Neuroimmunol 47 (2): 115-22. PMID 8370765.
Links
|